5'Nucleotidase Market - Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: 568D549233CCEN
Market Monitor Global

Abstracts

5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - 5'-Nucleotidase (5NT) is an intrinsic membrane glycoprotein that is present as an enzyme in a wide variety of mammalian cells. It catalyzes the phosphorylytic cleavage of 5'nucleotides.

This report contains market size and forecasts of 5'Nucleotidase in Global, including the following market information:

Global 5'Nucleotidase Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global 5'Nucleotidase market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Single Dose Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of 5'Nucleotidase include Bristol-Myers Squibb, Corvus Pharmaceuticals, Innate Pharma, MedImmune, Surface Oncology and Vitae Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 5'Nucleotidase companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global 5'Nucleotidase Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global 5'Nucleotidase Market Segment Percentages, by Type, 2021 (%)

• Single Dose
• Combination Therapy

Global 5'Nucleotidase Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global 5'Nucleotidase Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgical Centers
• Others

Global 5'Nucleotidase Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global 5'Nucleotidase Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies 5'Nucleotidase revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies 5'Nucleotidase revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bristol-Myers Squibb
• Corvus Pharmaceuticals
• Innate Pharma
• MedImmune
• Surface Oncology
• Vitae Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 5'Nucleotidase Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global 5'Nucleotidase Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL 5'NUCLEOTIDASE OVERALL MARKET SIZE

2.1 Global 5'Nucleotidase Market Size: 2021 VS 2028
2.2 Global 5'Nucleotidase Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top 5'Nucleotidase Players in Global Market
3.2 Top Global 5'Nucleotidase Companies Ranked by Revenue
3.3 Global 5'Nucleotidase Revenue by Companies
3.4 Top 3 and Top 5 5'Nucleotidase Companies in Global Market, by Revenue in 2021
3.5 Global Companies 5'Nucleotidase Product Type
3.6 Tier 1, Tier 2 and Tier 3 5'Nucleotidase Players in Global Market
  3.6.1 List of Global Tier 1 5'Nucleotidase Companies
  3.6.2 List of Global Tier 2 and Tier 3 5'Nucleotidase Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global 5'Nucleotidase Market Size Markets, 2021 & 2028
  4.1.2 Single Dose
  4.1.3 Combination Therapy
4.2 By Type - Global 5'Nucleotidase Revenue & Forecasts
  4.2.1 By Type - Global 5'Nucleotidase Revenue, 2017-2022
  4.2.2 By Type - Global 5'Nucleotidase Revenue, 2023-2028
  4.2.3 By Type - Global 5'Nucleotidase Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global 5'Nucleotidase Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Others
5.2 By Application - Global 5'Nucleotidase Revenue & Forecasts
  5.2.1 By Application - Global 5'Nucleotidase Revenue, 2017-2022
  5.2.2 By Application - Global 5'Nucleotidase Revenue, 2023-2028
  5.2.3 By Application - Global 5'Nucleotidase Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global 5'Nucleotidase Market Size, 2021 & 2028
6.2 By Region - Global 5'Nucleotidase Revenue & Forecasts
  6.2.1 By Region - Global 5'Nucleotidase Revenue, 2017-2022
  6.2.2 By Region - Global 5'Nucleotidase Revenue, 2023-2028
  6.2.3 By Region - Global 5'Nucleotidase Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America 5'Nucleotidase Revenue, 2017-2028
  6.3.2 US 5'Nucleotidase Market Size, 2017-2028
  6.3.3 Canada 5'Nucleotidase Market Size, 2017-2028
  6.3.4 Mexico 5'Nucleotidase Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe 5'Nucleotidase Revenue, 2017-2028
  6.4.2 Germany 5'Nucleotidase Market Size, 2017-2028
  6.4.3 France 5'Nucleotidase Market Size, 2017-2028
  6.4.4 U.K. 5'Nucleotidase Market Size, 2017-2028
  6.4.5 Italy 5'Nucleotidase Market Size, 2017-2028
  6.4.6 Russia 5'Nucleotidase Market Size, 2017-2028
  6.4.7 Nordic Countries 5'Nucleotidase Market Size, 2017-2028
  6.4.8 Benelux 5'Nucleotidase Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia 5'Nucleotidase Revenue, 2017-2028
  6.5.2 China 5'Nucleotidase Market Size, 2017-2028
  6.5.3 Japan 5'Nucleotidase Market Size, 2017-2028
  6.5.4 South Korea 5'Nucleotidase Market Size, 2017-2028
  6.5.5 Southeast Asia 5'Nucleotidase Market Size, 2017-2028
  6.5.6 India 5'Nucleotidase Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America 5'Nucleotidase Revenue, 2017-2028
  6.6.2 Brazil 5'Nucleotidase Market Size, 2017-2028
  6.6.3 Argentina 5'Nucleotidase Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa 5'Nucleotidase Revenue, 2017-2028
  6.7.2 Turkey 5'Nucleotidase Market Size, 2017-2028
  6.7.3 Israel 5'Nucleotidase Market Size, 2017-2028
  6.7.4 Saudi Arabia 5'Nucleotidase Market Size, 2017-2028
  6.7.5 UAE 5'Nucleotidase Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bristol-Myers Squibb
  7.1.1 Bristol-Myers Squibb Corporate Summary
  7.1.2 Bristol-Myers Squibb Business Overview
  7.1.3 Bristol-Myers Squibb 5'Nucleotidase Major Product Offerings
  7.1.4 Bristol-Myers Squibb 5'Nucleotidase Revenue in Global Market (2017-2022)
  7.1.5 Bristol-Myers Squibb Key News
7.2 Corvus Pharmaceuticals
  7.2.1 Corvus Pharmaceuticals Corporate Summary
  7.2.2 Corvus Pharmaceuticals Business Overview
  7.2.3 Corvus Pharmaceuticals 5'Nucleotidase Major Product Offerings
  7.2.4 Corvus Pharmaceuticals 5'Nucleotidase Revenue in Global Market (2017-2022)
  7.2.5 Corvus Pharmaceuticals Key News
7.3 Innate Pharma
  7.3.1 Innate Pharma Corporate Summary
  7.3.2 Innate Pharma Business Overview
  7.3.3 Innate Pharma 5'Nucleotidase Major Product Offerings
  7.3.4 Innate Pharma 5'Nucleotidase Revenue in Global Market (2017-2022)
  7.3.5 Innate Pharma Key News
7.4 MedImmune
  7.4.1 MedImmune Corporate Summary
  7.4.2 MedImmune Business Overview
  7.4.3 MedImmune 5'Nucleotidase Major Product Offerings
  7.4.4 MedImmune 5'Nucleotidase Revenue in Global Market (2017-2022)
  7.4.5 MedImmune Key News
7.5 Surface Oncology
  7.5.1 Surface Oncology Corporate Summary
  7.5.2 Surface Oncology Business Overview
  7.5.3 Surface Oncology 5'Nucleotidase Major Product Offerings
  7.5.4 Surface Oncology 5'Nucleotidase Revenue in Global Market (2017-2022)
  7.5.5 Surface Oncology Key News
7.6 Vitae Pharmaceuticals
  7.6.1 Vitae Pharmaceuticals Corporate Summary
  7.6.2 Vitae Pharmaceuticals Business Overview
  7.6.3 Vitae Pharmaceuticals 5'Nucleotidase Major Product Offerings
  7.6.4 Vitae Pharmaceuticals 5'Nucleotidase Revenue in Global Market (2017-2022)
  7.6.5 Vitae Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. 5'Nucleotidase Market Opportunities & Trends in Global Market
Table 2. 5'Nucleotidase Market Drivers in Global Market
Table 3. 5'Nucleotidase Market Restraints in Global Market
Table 4. Key Players of 5'Nucleotidase in Global Market
Table 5. Top 5'Nucleotidase Players in Global Market, Ranking by Revenue (2021)
Table 6. Global 5'Nucleotidase Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global 5'Nucleotidase Revenue Share by Companies, 2017-2022
Table 8. Global Companies 5'Nucleotidase Product Type
Table 9. List of Global Tier 1 5'Nucleotidase Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 5'Nucleotidase Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global 5'Nucleotidase Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - 5'Nucleotidase Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - 5'Nucleotidase Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global 5'Nucleotidase Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - 5'Nucleotidase Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - 5'Nucleotidase Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global 5'Nucleotidase Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global 5'Nucleotidase Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global 5'Nucleotidase Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America 5'Nucleotidase Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America 5'Nucleotidase Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe 5'Nucleotidase Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe 5'Nucleotidase Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia 5'Nucleotidase Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia 5'Nucleotidase Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America 5'Nucleotidase Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America 5'Nucleotidase Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa 5'Nucleotidase Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa 5'Nucleotidase Revenue, (US$, Mn), 2023-2028
Table 30. Bristol-Myers Squibb Corporate Summary
Table 31. Bristol-Myers Squibb 5'Nucleotidase Product Offerings
Table 32. Bristol-Myers Squibb 5'Nucleotidase Revenue (US$, Mn), (2017-2022)
Table 33. Corvus Pharmaceuticals Corporate Summary
Table 34. Corvus Pharmaceuticals 5'Nucleotidase Product Offerings
Table 35. Corvus Pharmaceuticals 5'Nucleotidase Revenue (US$, Mn), (2017-2022)
Table 36. Innate Pharma Corporate Summary
Table 37. Innate Pharma 5'Nucleotidase Product Offerings
Table 38. Innate Pharma 5'Nucleotidase Revenue (US$, Mn), (2017-2022)
Table 39. MedImmune Corporate Summary
Table 40. MedImmune 5'Nucleotidase Product Offerings
Table 41. MedImmune 5'Nucleotidase Revenue (US$, Mn), (2017-2022)
Table 42. Surface Oncology Corporate Summary
Table 43. Surface Oncology 5'Nucleotidase Product Offerings
Table 44. Surface Oncology 5'Nucleotidase Revenue (US$, Mn), (2017-2022)
Table 45. Vitae Pharmaceuticals Corporate Summary
Table 46. Vitae Pharmaceuticals 5'Nucleotidase Product Offerings
Table 47. Vitae Pharmaceuticals 5'Nucleotidase Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. 5'Nucleotidase Segment by Type in 2021
Figure 2. 5'Nucleotidase Segment by Application in 2021
Figure 3. Global 5'Nucleotidase Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global 5'Nucleotidase Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global 5'Nucleotidase Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by 5'Nucleotidase Revenue in 2021
Figure 8. By Type - Global 5'Nucleotidase Revenue Market Share, 2017-2028
Figure 9. By Application - Global 5'Nucleotidase Revenue Market Share, 2017-2028
Figure 10. By Region - Global 5'Nucleotidase Revenue Market Share, 2017-2028
Figure 11. By Country - North America 5'Nucleotidase Revenue Market Share, 2017-2028
Figure 12. US 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 13. Canada 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe 5'Nucleotidase Revenue Market Share, 2017-2028
Figure 16. Germany 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 17. France 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 19. Italy 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 20. Russia 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia 5'Nucleotidase Revenue Market Share, 2017-2028
Figure 24. China 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 25. Japan 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 28. India 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America 5'Nucleotidase Revenue Market Share, 2017-2028
Figure 30. Brazil 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa 5'Nucleotidase Revenue Market Share, 2017-2028
Figure 33. Turkey 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 34. Israel 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 36. UAE 5'Nucleotidase Revenue, (US$, Mn), 2017-2028
Figure 37. Bristol-Myers Squibb 5'Nucleotidase Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Corvus Pharmaceuticals 5'Nucleotidase Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Innate Pharma 5'Nucleotidase Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. MedImmune 5'Nucleotidase Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Surface Oncology 5'Nucleotidase Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Vitae Pharmaceuticals 5'Nucleotidase Revenue Year Over Year Growth (US$, Mn) & (2017-2022)